Home › Funds › TOWER BRIDGE ADVISORS › NVS
TOWER BRIDGE ADVISORS position in NVS
Novartis Ag Sponsored ADR · Health Care
TOWER BRIDGE ADVISORS reported holding 69,187 shares of NVS (Novartis Ag Sponsored ADR) in its Q3 2026 13F filing — a position valued at US$9.9M, representing 0.89% of its reported portfolio and ranking #30 among its reported holdings. TOWER BRIDGE ADVISORS has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How TOWER BRIDGE ADVISORS's NVS position evolved
TOWER BRIDGE ADVISORS first disclosed a stake in NVS in Q3 2023 at 92,078 shares (US$9.4M). The position peaked in Q1 2026 at 71,531 shares, worth US$10.9M. Across 13 filings, TOWER BRIDGE ADVISORS increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 69,187 shares valued at US$9.9M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 92.08K | $9.38M | New |
| Q4 2023 | 91.01K | $9.19M | Reduce |
| Q1 2024 | 84.97K | $8.22M | Reduce |
| Q2 2024 | 83.36K | $8.87M | Reduce |
| Q3 2024 | 81.34K | $9.36M | Reduce |
| Q4 2024 | 79.30K | $7.72M | Reduce |
| Q1 2025 | 77.94K | $8.69M | Reduce |
| Q2 2025 | 74.34K | $9.00M | Reduce |
| Q3 2025 | 73.34K | $9.40M | Reduce |
| Q4 2025 | 70.90K | $9.78M | Reduce |
| Q1 2026 | 71.53K | $10.93M | Add |
| Q2 2026 | 69.42K | $10.88M | Reduce |
| Q3 2026 | 69.19K | $9.86M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVS and 13F data
NVS (Novartis Ag Sponsored ADR) is a Health Care company. 20 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.39B), PRIMECAP MANAGEMENT CO/CA/ (US$938.9M), LOOMIS SAYLES & CO L P (US$689.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVS
- Fisher Asset Management, LLC 16.76M sh · $2.39B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.59M sh · $938.89M · Q3 2026
- LOOMIS SAYLES & CO L P 4.83M sh · $689.20M · Q3 2026
- NATIXIS ADVISORS, LLC 2.39M sh · $374.02M · Q2 2026
- Cullen Capital Management, LLC 1.95M sh · $278.55M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 1.72M sh · $250.18M · Q3 2026
More on TOWER BRIDGE ADVISORS
FAQ
How long has TOWER BRIDGE ADVISORS held NVS?
TOWER BRIDGE ADVISORS has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is TOWER BRIDGE ADVISORS's current position in NVS?
As of Q3 2026, TOWER BRIDGE ADVISORS holds 69.19K shares of NVS (Novartis Ag Sponsored ADR), valued at $9.86M, representing 0.89% of its reported portfolio and ranking #30.
Has TOWER BRIDGE ADVISORS been buying or selling NVS?
In the latest 13F filing (Q3 2026), TOWER BRIDGE ADVISORS held unchanged its position in NVS. The position peaked in Q1 2026 at 71.53K shares.
Which other funds hold NVS?
Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.